Several studies have demonstrated the feasibility of molecular screening
of tumour samples for matching patients with cancer to targeted therapies.
There is substantial clinical impact of performing genetic profiling
of tumour samples in order to identify specific mutations and match those mutations with targeted therapies; one of the earliest forms of «personalised» or «precision» medicine.
Not exact matches
The team found that exposing
samples of human glioblastoma
tumours grown in a dish to the Zika virus destroyed the cancer stem cells.
Scientists at The Institute
of Cancer Research, London, analysed 177
tumour samples from patients with stage I non-seminomatous
tumours enrolled in clinical trials through the Medical Research Council (MRC) Clinical Trials Unit.
In each person, the team found more than 100 mutations in the various
tumour samples analysed; only about one - third
of them occurred in all
samples.
It will soon be time to take
samples of the 3 cm invisible
tumour hidden in the patient's left lung.
Nearly all cancers are still diagnosed by doctors taking a
sample of the
tumour, a so - called biopsy, then slicing it thinly and staining it with two vegetable dyes used for more than 100 years.
However, biopsies are prone to
sampling errors and so may not be representative
of the
tumour as a whole.
In research funded by Sparks charity, Great Ormond Street Hospital Children's Charity and Cancer Research UK, researchers at the University
of Cambridge have developed a test for blood and cerebrospinal fluid
samples that looks for a specific panel
of four pieces
of short genetic code known as microRNAs, which are found in greater quantities in malignant germ cell
tumours.
Thanks to our surgeons, we were able to obtain
samples along normal - looking ducts close to the nipple and close to the
tumour, as well as
samples on the opposite side
of the same breast to study and compare.»
«We therefore looked for patient characteristics that would account for this result; next generation sequencing (NGS)
of the genes
of interest was performed on the archival tissue
samples from the patients» primary
tumours,» explained Ciardiello.
In a study
of 40 patients with high grade serous ovarian cancer, the researchers monitored
tumour DNA that could be detected in a blood
sample taken before each chemotherapy treatment.
The research team with international collaborators analysed more than 100 patient
samples from ovarian and other cancer types to discover a distinct population
of cells found in some
tumours.
Prostate cancer researchers have mapped the impact
of an acquired mutation that alters epigenetic identity, the make - up
of DNA, in about 50 %
of patient
tumour samples.
This is in part due to the difficulty in acquiring
samples of tumours that have spread to other tissues.
The team analysed levels
of PTEN in around 500 ovarian
tumour samples.
Samples of tumours from bowel cancer patients given different doses
of resveratrol showed that even lower doses can get into cancer cells and potentially affect processes involved in
tumour growth.
To do this, they switched from using dead
tumour cell
samples to patient - derived
tumour cell lines, in which fresh
samples of a person's
tumour are grafted onto mice and grown to the required volumes.
In lab experiments, the research team used cell lines derived from 40 patient
tumour samples to identify that CD151 contributes to the survival
of cells
of high - grade serous ovarian cancer origin.
The authors
of the work also show that NANOG is increased in patient - derived
tumour samples from stratified epithelia.
In collaboration with Dr Gabriele Bonatz from the Augusta clinics in Bochum (Brustzentrum), Hatt's team confirmed the existence
of TRPV1 in
tumour cells in nine different
samples from patients suffering from breast cancer.
The outcome was the same; but Colletta's group could compare
samples of tumours from women who had been taking tamoxifen with those who had never taken the drug.
These
samples are then transferred to a mass spectrometer, which compares the combination
of biomolecules with reference data collected from
tumours and healthy tissue.
The method has been tested on many thousands
of samples where the primary
tumour was already identified, and it has proven extremely precise.
Oncologists were then required to obtain government approval before sending
tumour samples out
of the country for testing.
Doctors will take blood
samples and
tumour biopsies at intervals up to two months after the injection
of TILs.
Carried out in cells in the laboratory, in mice and in
samples from patients»
tumours, the researchers showed this «safe haven» lets melanoma cells turn on a parallel set
of cell signals that helps them survive.
By conducting an RNA - sequencing experiment
of 103 matched
tumour and normal colon mucosa
samples from Danish CRC patients, 90
of which were germline - genotyped, researchers from the collaborative European project SYSCOL show that both inherited and acquired mutations in non-coding regions
of the genome also contribute to cancer development and progression (Linda Koch, Nature Reviews Genetics).
The technique is insensitive to the level
of mutated cancer cells in the
sample, and the information about mutations can be linked directly to the way the
tumour cells are growing in the tissue
sample.
As part
of this global aim we have demonstrated that one
of the most abundant stromal populations, the cancer associated fibroblasts (CAFs), can
sample and present
tumour antigen to T cells in an antigen specific - antigen dependent manner resulting in T cell deletion.
Scientists looked at
tumour samples and found that the drug penetrates the core
of the
tumour as well as the surrounding areas which contain smaller numbers
of cancerous cells.
Clinical genomics involves the analysis
of clinical
tumour samples.
From the dogs»
samples, researchers were able to prove that some cells in the vicinity
of tumours act the same way as the cells would, in similar circumstances, behave in humans.
This may occur before surgery, if a small
sample of dog
tumour is collected.
When he commenced radiotherapy for treatment
of the
tumour in 2005 his consultant referred him to the Care Fertility Clinic in Northampton so that
samples of his sperm could be taken and frozen for use in future reproduction.